Drug Detail:Tick-borne encephalitis vaccine (Tick-borne encephalitis vaccine)
Drug Class: Viral vaccines
Usual Adult Dose for Tick-Borne Encephalitis Vaccination
0.5 mL IM each dose
Primary Vaccination Schedule:
- First dose: Day 0
- Second dose: 14 days to 3 months after the first dose
- Third dose: 5 to 12 months after the second dose
Comments:
- The primary immunization series should be completed at least 1 week before potential exposure to tick-borne encephalitis virus (TBEV).
- A booster dose (fourth dose) may be administered at least 3 years after completion of the primary immunization series if continued exposure or re-exposure to TBEV is expected.
Use: For active immunization to prevent tick-borne encephalitis
Usual Pediatric Dose for Tick-Borne Encephalitis Vaccination
1 through 15 years: 0.25 mL IM each dose
16 years or older: 0.5 mL IM each dose
Primary Vaccination Schedule:
- First dose: Day 0
- Second dose:
- Aged 1 through 15 years: 1 to 3 months after the first dose
- Aged 16 years or older: 14 days to 3 months after the first dose
- Third dose: 5 to 12 months after the second dose
Comments:
- The primary immunization series should be completed at least 1 week before potential exposure to TBEV.
- A booster dose (fourth dose) may be administered at least 3 years after completion of the primary immunization series if continued exposure or re-exposure to TBEV is expected.
Use: For active immunization to prevent tick-borne encephalitis
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Data not available
Precautions
CONTRAINDICATIONS:
Severe allergic reaction (e.g., anaphylaxis) to the active component or any of the ingredients
Safety and efficacy have not been established in patients younger than 1 year.
Consult WARNINGS section for additional precautions.
Dialysis
Data not available
Other Comments
Administration advice:
- For IM use only
- Administer by IM injection.
Storage requirements:
- Store refrigerated at 2C to 8C (36F to 46F).
- Keep syringe in outer carton to protect from light.
- Do not freeze; discard if the vaccine has been frozen.
Reconstitution/preparation techniques:
- Before administration, the vaccine should be brought to room temperature.
- Before administration, the vaccine suspension should be thoroughly mixed by shaking well; after shaking, the vaccine should be a homogenous off-white, opalescent suspension.
- The manufacturer product information should be consulted.
Patient advice:
- It is important to complete the approved 3-dose primary immunization series before potential exposure to TBEV.
- Report any side effects to a health care professional.
